Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Marcela Torres, MD, Tyler Hamby, PhD, Sarah Philip, MDcal Student, Jo Ann Tilley, DNP, APRN, CPNP

Blood (2019) 134 (Supplement_1): 3666.

https://doi.org/10.1182/blood-2019-132082

Published: 2019

Journal Articles

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis

Andrew Sochacki, MD, Cosmin Adrian Bejan, PhD, Shilin Zhao, PhD, Travis Spaulding, MD, Shannon Stockton, MD, Alexander Silver, Dixon Dorand, MD PhD, Siwei Zhang, PhD, Thomas Stricker, MD PhD, Yaomin Xu, PhD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2959.

https://doi.org/10.1182/blood-2019-121513

Published: 2019

Journal Articles

The Dual PI3K-δ/γ Inhibitor Duvelisib in Combination with the Bcl-2 Inhibitor Venetoclax Shows Promising Responses in Richter Syndrome-PDX Models

Andrea Iannello, PhD, Francesca Arruga, PhD, Nicoletta Vitale, PhD, Elisa Marchi, Richard R. Furman, MD, John N. Allan, MD, Silvia Coma, PhD, Jonathan A. Pachter, PhD, Silvia Deaglio, MD PhD, Tiziana Vaisitti, PhD

Blood (2019) 134 (Supplement_1): 2862.

https://doi.org/10.1182/blood-2019-125754

Published: 2019

Journal Articles

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Blood (2019) 134 (Supplement_1): 1082.

https://doi.org/10.1182/blood-2019-122665

Published: 2019

Journal Articles

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

Spero Cataland, MD, Marie Scully, Flora Peyvandi, MD PhD, Paul Knoebl, MD, Johanna A. Kremer Hovinga, MD Prof, Paul Coppo, MD PhD, Ara Metjian, MD, Javier De La Rubia, Katerina Pavenski, MD, Hilde De Winter, MD, Filip Callewaert

Blood (2019) 134 (Supplement_1): 4908.

https://doi.org/10.1182/blood-2019-123124

Published: 2019

Journal Articles

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity

Paul Coppo, MD PhD, Spero Cataland, MD, Flora Peyvandi, MD PhD, Paul Knoebl, MD, Marie Scully, Johanna A. Kremer Hovinga, MD Prof, Ara Metjian, MD, Javier De La Rubia, Katerina Pavenski, MD, Hilde De Winter, MD, Rui de Passos Sousa, Filip Callewaert

Blood (2019) 134 (Supplement_1): 2366.

https://doi.org/10.1182/blood-2019-123720

Published: 2019

Journal Articles

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Jose Thiago de Souza Castro, Letícia Rittner, Simone Appenzeller, Gabriela G Yamaguti-Hayakawa, MD, Marina Colella, Erich V De Paula, MD PhD, Joyce Maria Annichino- Bizzacchi, MD PhD, Fabiano Reis, Fernanda Andrade Orsi, MD

Blood (2019) 134 (Supplement_1): 4894.

https://doi.org/10.1182/blood-2019-129144

Published: 2019

Journal Articles

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Lana A Castellucci, MD, Philip Chiang

Blood (2018) 132 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2018-99-118369

Published: 2018

Journal Articles

Acquired Thrombotic Thrombocytopenic Purpura and Acute Pancreatitis: Variable and Reciprocal Pathophysiologic Relationships

Qian Qin, MD, Cesar Gentille Sanchez, MD, Xinyu Nan, MD, Lawrence Rice, MDBA

Blood (2017) 130 (Supplement 1): 3637.

https://doi.org/10.1182/blood.V130.Suppl_1.3637.3637

Published: 2017

Journal Articles

Host Genetic Factors in Glucose-6-Phosphate Dehydrogenase and Cytochrome B5 Reductase 3 Affect the Susceptibility of Developing Severe Malarial Anemia

Binal N. Shah, PhD, Philip E Thuma, N. Scott Reading, PhD, Josef T. Prchal, MD, Victor R. Gordeuk, MD

Blood (2016) 128 (22): 2438.

https://doi.org/10.1182/blood.V128.22.2438.2438

Published: 2016

Journal Articles

N-Acetylcysteine Treatment in Two Patients with Relapsed Thrombotic Thrombocytopenic Purpura Increased ADAMTS13 Activity, Free Thiol Concentration in Plasma, and Inhibited Platelet Activation

Junmei Chen, PhD, Tahsin Özpolat, MD, Colette Norby, MS, Jennie Le, BS, Minhua Ling, PhD, Shelby A Cate, BS, Dominic W Chung, PhD, Xiaoyun Fu, PhD, Barbara Konkle, MD, Jose A. Lopez, MD

Blood (2015) 126 (23): 239.

https://doi.org/10.1182/blood.V126.23.239.239

Published: 2015

Journal Articles

Cerebral Arterial Velocities in SCA-Children with Abnormal Doppler Are Reduced and Normalized More Frequently after Transplantation Than after Transfusion Program (French National Trial “Drepagreffe” AP-HP N°: NCT 01340404)

Blood (2014) 124 (21): 561.

https://doi.org/10.1182/blood.V124.21.561.561

Published: 2014

Journal Articles

Disruption of EPCR-Dependent Functions By Plasmodium Falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Can be Rescued By a Soluble EPCR Variant

Jens E.V. Petersen, Eveline A. Bouwens, PhD, Ibai Tamayo, PhD, Louis Turner, PhD, Christian Wang, PhD, Monique Stins, PhD, Thor G. Theander, PhD, José Hermida, PhD, Thomas Lavstsen, PhD, Laurent O. Mosnier, PhD

Blood (2014) 124 (21): 577.

https://doi.org/10.1182/blood.V124.21.577.577

Published: 2014

Journal Articles

Characteristics of Intracranial Haemorrhage in Haemophilic Children-Report in Single Center in China

Wenjiao Ding, Xiaoqin Feng, MDPhD, Jing Sun, MD

Blood (2014) 124 (21): 5063.

https://doi.org/10.1182/blood.V124.21.5063.5063

Published: 2014

Journal Articles

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

Ling Pan, MD, PhD, Meng Chen, Li Zhang, MD, PhD, Yongqian Jia, MD, PhD, Ting Niu, MD, PhD

Blood (2013) 122 (21): 5566.

https://doi.org/10.1182/blood.V122.21.5566.5566

Published: 2013

Journal Articles

Determinants Of Mortality and Survival In Children With Sickle Cell Disease (SCD) In Sub Saharan Africa

Tom Adamkiewicz, MD, MSCR, FRCP(C), Adel Driss, PhD, MSc, BSc, Hyacinth I Hyacinth, MBBS, MPH, Jacqueline Hibbert, PhD, Jonathan K Stiles, PhD

Blood (2013) 122 (21): 4676.

https://doi.org/10.1182/blood.V122.21.4676.4676

Published: 2013

Journal Articles

Implementation of an End-of-Life Care Pathway in Cancer Patients

Meinolf Karthaus, J Riesle-Keil, Ursula Weber, Ingeburg Wolf

Blood (2012) 120 (21): 4689.

https://doi.org/10.1182/blood.V120.21.4689.4689

Published: 2012

Journal Articles

Azacitidine (AZA) Combined with Idarubicin in Untreated Patients with High Risk MDS – Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies

Lionel Ades, MD, PhD, Benoit de Renzis, Ramzi Jeddi, MD, Jacques Delaunay, MD, Thorsten Braun, Mathilde Hunault Berger, MD, PhD, Aspasia Stamatoullas, Laurence Sanhes, MD, Benedicte Samey, Fatiha Chermat, Baklis Meddeb, Pierre Fenaux, MD, PhD

Blood (2012) 120 (21): 1720.

https://doi.org/10.1182/blood.V120.21.1720.1720

Published: 2012

Journal Articles

High Efficiency of ICE (Ifosfamide-Carboplatin-Etoposide) in Relapse/Refractory Primary Central-Nervous System and Intra-Ocular Non Hodgkin Lymphoma, After First Line Treatment Containing High Doses of Methotrexate and Cytarabine. A Monocentric Retrospective Study From 2010 to 2012 On 17 Cases

Sylvain Choquet, MD, Damien roos Weil, MD, Khe Hoang Xuan, MD, Nathalie Cassoux, Helene Merle-Beral, Veronique Leblond

Blood (2012) 120 (21): 3664.

https://doi.org/10.1182/blood.V120.21.3664.3664

Published: 2012

Journal Articles

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Fabrizio Foieni, MD, Andrea Zanichelli, MD, Anna Coerezza, MD, Roberto Castelli, MD, Lorena Maggioni, PhD, Chiara Suffritti, PhD, Erika Bonanni, Augusto B. Federici, MD, Marco Cicardi, MD

Blood (2011) 118 (21): 1596.

https://doi.org/10.1182/blood.V118.21.1596.1596

Published: 2011

NARROW

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis

The Dual PI3K-δ/γ Inhibitor Duvelisib in Combination with the Bcl-2 Inhibitor Venetoclax Shows Promising Responses in Richter Syndrome-PDX Models

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Acquired Thrombotic Thrombocytopenic Purpura and Acute Pancreatitis: Variable and Reciprocal Pathophysiologic Relationships

Host Genetic Factors in Glucose-6-Phosphate Dehydrogenase and Cytochrome B5 Reductase 3 Affect the Susceptibility of Developing Severe Malarial Anemia

N-Acetylcysteine Treatment in Two Patients with Relapsed Thrombotic Thrombocytopenic Purpura Increased ADAMTS13 Activity, Free Thiol Concentration in Plasma, and Inhibited Platelet Activation

Cerebral Arterial Velocities in SCA-Children with Abnormal Doppler Are Reduced and Normalized More Frequently after Transplantation Than after Transfusion Program (French National Trial “Drepagreffe” AP-HP N°: NCT 01340404)

Disruption of EPCR-Dependent Functions By Plasmodium Falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Can be Rescued By a Soluble EPCR Variant

Characteristics of Intracranial Haemorrhage in Haemophilic Children-Report in Single Center in China

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

Determinants Of Mortality and Survival In Children With Sickle Cell Disease (SCD) In Sub Saharan Africa

Implementation of an End-of-Life Care Pathway in Cancer Patients

Azacitidine (AZA) Combined with Idarubicin in Untreated Patients with High Risk MDS – Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies

High Efficiency of ICE (Ifosfamide-Carboplatin-Etoposide) in Relapse/Refractory Primary Central-Nervous System and Intra-Ocular Non Hodgkin Lymphoma, After First Line Treatment Containing High Doses of Methotrexate and Cytarabine. A Monocentric Retrospective Study From 2010 to 2012 On 17 Cases

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only